XML 30 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation (Tables)
6 Months Ended
Jul. 01, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Fair value of stock options granted to employees, officers and non-employee board members and ESPP shares granted to employees
Option Plan Shares. The fair value of the Company’s stock options granted to employees, officers and non-employee board members was estimated using the following weighted average assumptions:
 
Three months ended
 
Six months ended
 
July 1,
2012
 
July 3,
2011
 
July 1,
2012
 
July 3,
2011
Dividend yield
None
 
None
 
None
 
None
Expected volatility
0.40
 
0.43
 
0.43
 
0.43
Risk-free interest rate
0.53%
 
1.33%
 
0.61%
 
1.68%
Expected term
3.9 years
 
4.3 years
 
4.3 years
 
4.3 years
Estimated annual forfeiture rate
8.59%
 
8.57%
 
8.59%
 
8.57%
Weighted average fair value at grant date
$11.34
 
$16.11
 
$16.72
 
$17.75
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]
Employee Stock Purchase Plan Shares. The fair value of the Company’s ESPP shares issued to employees was estimated using the following weighted average assumptions:
 
Three months ended
 
Six months ended
 
July 1,
2012
 
July 3,
2011
 
July 1,
2012
 
July 3,
2011
Dividend yield
None
 
None
 
None
 
None
Expected volatility
0.38
 
0.43
 
0.38
 
0.43
Risk-free interest rate
0.15%
 
0.17%
 
0.15%
 
0.17%
Expected term
½ year
 
½ year
 
½ year
 
½ year
Weighted average fair value at purchase date
$12.24
 
$13.79
 
$12.24
 
$13.79
Stock options and stock appreciation rights
A summary of stock option and stock appreciation rights (“SARs”) activity under all of the Company’s share-based compensation plans as of July 1, 2012 and changes during the six months ended July 1, 2012 is presented below (in thousands, except for weighted average exercise price and remaining contractual term):
 
Shares
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term (Years)
 
Aggregate Intrinsic Value
Options and SARs outstanding at January 1, 2012
17,559

 
$
36.55

 
3.4
 
$
257,251

Granted
2,028

 
47.12

 
 
 


Exercised
(2,109
)
 
23.64

 
 
 
49,353

Forfeited
(164
)
 
33.30

 
 
 
 

Expired
(171
)
 
53.44

 
 
 
 

Options and SARs outstanding at July 1, 2012
17,143

 
39.26

 
3.5
 
101,671

Options and SARs vested and expected to vest after July 1, 2012, net of forfeitures
16,469

 
39.08

 
3.4
 
100,224

Options and SARs exercisable at July 1, 2012
11,013

 
39.12

 
2.4
 
73,039

Summary of the changes in RSUs outstanding
A summary of the changes in RSUs outstanding under the Company’s share-based compensation plans during the six months ended July 1, 2012 is presented below (in thousands, except for weighted average grant date fair value):
 
Shares
 
Weighted Average Grant Date Fair Value
 
Aggregate Intrinsic Value
Non-vested share units at January 1, 2012
2,051

 
$
40.22

 
$
100,913

Granted
1,536

 
45.50

 
 

Vested
(622
)
 
47.87

 
28,466

Forfeited
(72
)
 
43.62

 
 

Assumed through acquisition
59

 
46.63

 
 

Non-vested share units at July 1, 2012
2,952

 
43.47

 
107,687

Share-based compensation expense
The following tables set forth the detailed allocation of the share-based compensation expense (in thousands):
 
Three months ended
 
Six months ended
 
July 1,
2012
 
July 3,
2011
 
July 1,
2012
 
July 3,
2011
Share-based compensation expense by caption:
 
 
 
 
 
 
 
Cost of product revenues
$
1,923

 
$
1,090

 
$
3,460

 
$
2,032

Research and development
10,623

 
7,684

 
20,650

 
14,928

Sales and marketing
3,634

 
2,867

 
7,263

 
5,042

General and administrative
4,073

 
2,717

 
7,960

 
6,947

Total share-based compensation expense
20,253

 
14,358

 
39,333

 
28,949

Total tax benefit recognized
(4,676
)
 
(3,349
)
 
(9,845
)
 
(7,732
)
Decrease in net income
$
15,577

 
$
11,009

 
$
29,488

 
$
21,217

 
 
 
 
 
 
 
 
Share-based compensation expense by type of award:
 
 
 
 
 
 
 
Stock options and SARs
$
9,426

 
$
6,966

 
$
18,642

 
$
15,648

RSUs
8,608

 
5,271

 
16,502

 
9,110

ESPP
2,219

 
2,121

 
4,189

 
4,191

Total share-based compensation expense
20,253

 
14,358

 
39,333

 
28,949

Total tax benefit recognized
(4,676
)
 
(3,349
)
 
(9,845
)
 
(7,732
)
Decrease in net income
$
15,577

 
$
11,009

 
$
29,488

 
$
21,217

Fair value of options and RSUs
The total grant date fair value of options and RSUs vested was as follows (in thousands):
 
Three months ended
 
Six months ended
 
July 1,
2012
 
July 3,
2011
 
July 1,
2012
 
July 3,
2011
Fair value of options vested
$
8,214

 
$
7,458

 
$
22,974

 
$
19,401

Fair value of RSUs vested
4,283

 
1,227

 
23,584

 
10,345

Total fair value of options and RSUs vested
$
12,497

 
$
8,685

 
$
46,558

 
$
29,746